FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
14/08/2023
Voltar para busca
Dado oficial do USPTO
ANIMA BIOTECH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ANIMA BIOTECH
ST13
US500000079324231Classe
5, 42
Pedido
79324231
Registro
7014599
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
14/08/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
08/08/2021
Data de registro
04/04/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/04/2023
Última transação
04/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
US
Examinador
JOINER, KATINA
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Anima Biotech Inc.
Representantes
Jonathan D. Reichman, Esq. Hunton Andrews Kurth LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalssmall molecules therapeutic preparations for the regulation of mRNA translation and mRNA biologyused in the treatment of fibrosiscancersneurological diseasesinfectious diseasesgenetic diseasesother diseases; pharmaceutical and medical preparations and substances for the treatment of fibrosiscancersneurological diseasesinfectious diseasesgenetic diseasesother diseases; medical and pharmaceutical chemical preparations for the treatment of fibrosiscancersneurological diseasesinfectious diseasesgenetic diseasesother diseases; pharmaceutical preparations for RNA targeted therapeutics; therapeutic agents for acting on protein targets that regulate translational control of gene expression
Classe 42
Research and development of pharmaceuticalssmall molecule therapeutic preparations for the regulation of mRNA translation and mRNA biologyused in the treatment of fibrosiscancersneurological diseasesinfectious diseasesgenetic diseasesother diseases; research and development of pharmaceutical preparations; pharmaceutical drug development services; providing scientific research information in the field of pharmaceuticals and molecular biology; researchanalysisdevelopment in the field of pharmaceutical; research and development in the field of bio-therapeutics for the treatment of fibrosiscancersneurological diseasesinfectious diseasesgenetic diseasesother diseases; scientific investigations for medical purposes; pharmaceuticalmedical and scientific researchdevelopment; drug development and discovery; scientific and technological services and research relating to the field of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/07/2023
FIMP
FINAL DISPOSITION PROCESSED
21/07/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/07/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/03/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/03/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/03/2023
GPNX
NOTIFICATION PROCESSED BY IB
24/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/01/2023
PUBO
PUBLISHED FOR OPPOSITION
17/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/01/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/12/2022
RFNT
REFUSAL PROCESSED BY IB
05/07/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/06/2022
RFRR
REFUSAL PROCESSED BY MPU
14/06/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/05/2022
CNRT
NON-FINAL ACTION WRITTEN
13/05/2022
DOCK
ASSIGNED TO EXAMINER
06/05/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/11/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ANIMA BIOTECH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.